Persistent Link:
http://hdl.handle.net/10150/288899
Title:
The FP prostanoid receptor: Isoforms and functional studies
Author:
Pierce, Kristen Lynne, 1970-
Issue Date:
1998
Publisher:
The University of Arizona.
Rights:
Copyright © is held by the author. Digital access to this material is made possible by the University Libraries, University of Arizona. Further transmission, reproduction or presentation (such as public display or performance) of protected items is prohibited except with permission of the author.
Abstract:
Prostaglandin F₂(α) (PGF₂(α)) is a locally acting hormone derived from arachidonic acid that is involved in a diverse range of physiological functions including regulation of the corpus luteum and regulation of intraocular pressure. The goal of this research has been to characterize the signaling pathways activated by PGF₂(α). A receptor for PGF₂(α), the FP receptor, had been cloned from a number of species. Based on the cloning of other prostanoid receptors, we hypothesized that isoforms, or alternative splice variants of the FP receptor that differed in their functional coupling might exist. Using a corpus luteum library, we cloned a novel, truncated form of the FP prostanoid receptor, known as the FP(B) receptor isoform. To examine differences in signaling between the FP receptor isoforms, we have generated stable cell lines that express the original FP receptor, known as the FP(A) isoform and cells that express the FP(B) isoform. To date, no differences in the functional coupling between the receptor isoforms have been found. However, during the second messenger studies, we discovered that activation of either receptor isoform leads to changes in the cell morphology and in the cell cytoskeleton. Thus, treatment of the stable cell lines with PGF₂(α) leads to the retraction of cellular projections, and the boundaries between the cells appear less distinct. There is concomitant formation of actin stress fibers and increased tyrosine phosphorylation of p125 FAK. Understanding the molecular mechanisms underlying the PGF₂(α) induced changes in the cell morphology and in the cell cytoskeleton may be relevant for developing better treatments for glaucoma and other diseases.
Type:
text; Dissertation-Reproduction (electronic)
Keywords:
Health Sciences, Pharmacology.
Degree Name:
Ph.D.
Degree Level:
doctoral
Degree Program:
Graduate College; Pharmacology and Toxicology
Degree Grantor:
University of Arizona
Advisor:
Regan, John W.

Full metadata record

DC FieldValue Language
dc.language.isoen_USen_US
dc.titleThe FP prostanoid receptor: Isoforms and functional studiesen_US
dc.creatorPierce, Kristen Lynne, 1970-en_US
dc.contributor.authorPierce, Kristen Lynne, 1970-en_US
dc.date.issued1998en_US
dc.publisherThe University of Arizona.en_US
dc.rightsCopyright © is held by the author. Digital access to this material is made possible by the University Libraries, University of Arizona. Further transmission, reproduction or presentation (such as public display or performance) of protected items is prohibited except with permission of the author.en_US
dc.description.abstractProstaglandin F₂(α) (PGF₂(α)) is a locally acting hormone derived from arachidonic acid that is involved in a diverse range of physiological functions including regulation of the corpus luteum and regulation of intraocular pressure. The goal of this research has been to characterize the signaling pathways activated by PGF₂(α). A receptor for PGF₂(α), the FP receptor, had been cloned from a number of species. Based on the cloning of other prostanoid receptors, we hypothesized that isoforms, or alternative splice variants of the FP receptor that differed in their functional coupling might exist. Using a corpus luteum library, we cloned a novel, truncated form of the FP prostanoid receptor, known as the FP(B) receptor isoform. To examine differences in signaling between the FP receptor isoforms, we have generated stable cell lines that express the original FP receptor, known as the FP(A) isoform and cells that express the FP(B) isoform. To date, no differences in the functional coupling between the receptor isoforms have been found. However, during the second messenger studies, we discovered that activation of either receptor isoform leads to changes in the cell morphology and in the cell cytoskeleton. Thus, treatment of the stable cell lines with PGF₂(α) leads to the retraction of cellular projections, and the boundaries between the cells appear less distinct. There is concomitant formation of actin stress fibers and increased tyrosine phosphorylation of p125 FAK. Understanding the molecular mechanisms underlying the PGF₂(α) induced changes in the cell morphology and in the cell cytoskeleton may be relevant for developing better treatments for glaucoma and other diseases.en_US
dc.typetexten_US
dc.typeDissertation-Reproduction (electronic)en_US
dc.subjectHealth Sciences, Pharmacology.en_US
thesis.degree.namePh.D.en_US
thesis.degree.leveldoctoralen_US
thesis.degree.disciplineGraduate Collegeen_US
thesis.degree.disciplinePharmacology and Toxicologyen_US
thesis.degree.grantorUniversity of Arizonaen_US
dc.contributor.advisorRegan, John W.en_US
dc.identifier.proquest9906529en_US
dc.identifier.bibrecord.b38874222en_US
All Items in UA Campus Repository are protected by copyright, with all rights reserved, unless otherwise indicated.